CoChat

Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients

Open access
Guo, Yi, Luo, Shiyun, Ye, Yongxin, Yin, Songping, Fan, Jiahua, Xia, Min · 2021 · The Journal of Clinical Endocrinology & Metabolism
Cited by 191

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Context: Intermittent fasting (IF) is an effective strategy to improve cardiometabolic health. Objective: The objective of this work is to examine the effects of IF on cardiometabolic risk factors and the gut microbiota in patients with metabolic syndrome (MS). Design and Setting: A randomized clinical trial was conducted at a community health service center. Patients: Participants included adults with MS, age 30 to 50 years. Intervention: Intervention consisted of 8 weeks of “2-day” modified IF. Main Outcome Measure: Cardiometabolic risk factors including body composition, oxidative stress, inflammatory cytokines, and endothelial function were assessed at baseline and at 8 weeks. The diversity, composition, and functional pathways of the gut microbiota, as well as circulating gut-derived metabolites, were measured. Results: Thirty-nine patients with MS were included: 21 in the IF group and 18 in the control group. On fasting days, participants in the IF group reduced 69% of their calorie intake compared to nonfasting days. The 8-week IF significantly reduced fat mass, ameliorated oxidative stress, modulated inflammatory cytokines, and improved vasodilatory parameters. Furthermore, IF induced significant changes in gut microbiota communities, increased the production of short-chain fatty acids, and decreased the circulating levels of lipopolysaccharides. The gut microbiota alteration attributed to the IF was significantly associated with cardiovascular risk factors and resulted in distinct genetic shifts of carbohydrate metabolism in the gut community. Conclusion: IF induces a significant alteration of the gut microbial community and functional pathways in a manner closely associated with the mitigation of cardiometabolic risk factors. The study provides potential mechanistic insights into the prevention of adverse outcomes associated with MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa644

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 24

  1. O’Neill, 2015, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies, Obes Rev., 16, 1, 10.1111/obr.12229 · DOI · Paper page
  2. Girman, 2004, The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), Am J Cardiol., 93, 136, 10.1016/j.amjcard.2003.09.028 · DOI · Paper page
  3. Malik, 2004, Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults, Circulation., 110, 1245, 10.1161/01.CIR.0000140677.20606.0E · DOI · Paper page
  4. Varady, 2007, Alternate-day fasting and chronic disease prevention: a review of human and animal trials, Am J Clin Nutr., 86, 7, 10.1093/ajcn/86.1.7 · DOI · Paper page
  5. Varady, 2009, Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults, Am J Clin Nutr., 90, 1138, 10.3945/ajcn.2009.28380 · DOI · Paper page
  6. Heilbronn, 2005, Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting, Obes Res., 13, 574, 10.1038/oby.2005.61 · DOI · Paper page
  7. Antoni, 2018, Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants, Br J Nutr., 119, 507, 10.1017/S0007114517003890 · DOI · Paper page
  8. Beli, 2018, Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice, Diabetes., 67, 1867, 10.2337/db18-0158 · DOI · Paper page
  9. Cignarella, 2018, Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota, Cell Metab., 27, 1222, 10.1016/j.cmet.2018.05.006 · DOI · Paper page
  10. Lagier, 2012, Human gut microbiota: repertoire and variations, Front Cell Infect Microbiol., 2, 136, 10.3389/fcimb.2012.00136 · DOI · Paper page
  11. Guo, Data from: supplemental materials_intermittent fasting improves cardiometabolic risk factors and alters the gut microbiota in metabolic syndrome patients, figshare.
  12. International Diabetes Federation, Worldwide definition for use in clinical practice. In: The IDF consensus worldwide definition of the METABOLIC SYNDROME. Consensus statement; 2006:10-12
  13. Bryk, 2002, Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein, Science., 295, 1073, 10.1126/science.1067798 · DOI · Paper page
  14. Calderone, 2008, A ketoreductase domain in the PksJ protein of the bacillaene assembly line carries out both α- and β-ketone reduction during chain growth, Proc Natl Acad Sci U S A., 105, 12809, 10.1073/pnas.0806305105 · DOI
  15. Remely, 2014, Epigenetic influence of butyrate producing bacteria in metabolic syndrome. In: Li CJ, ed, 177
  16. Barnosky, 2014, Intermittent fasting vs. daily calorie restriction for type 2 diabetes prevention: a review of human findings, Transl Res., 164, 302, 10.1016/j.trsl.2014.05.013 · DOI · Paper page
  17. Koh, 2005, Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions, J Am Coll Cardiol., 46, 1978, 10.1016/j.jacc.2005.06.082 · DOI · Paper page
  18. Klempel, 2011, Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans, Nutr Rev., 69, 145, 10.1111/j.1753-4887.2011.00373.x · DOI · Paper page
  19. Zoetendal, 2018, Endothelial dysfunction: what is the role of the microbiota?, Gut., 67, 201, 10.1136/gutjnl-2017-314012 · DOI
  20. Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature., 457, 480, 10.1038/nature07540 · DOI · Paper page
  21. O’Sullivan, 2017, Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes, J Clin Invest., 127, 4394, 10.1172/JCI95995 · DOI
  22. Robbins, 2019, Association of dimethylguanidino valeric acid with partial resistance to metabolic health benefits of regular exercise, JAMA Cardiol., 4, 636, 10.1001/jamacardio.2019.1573 · DOI
  23. Kasahara, 2018, Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model, Nat Microbiol., 3, 1461, 10.1038/s41564-018-0272-x · DOI · Paper page
  24. Kim, 2020, Altered gut microbiome profile in patients with pulmonary arterial hypertension, Hypertension., 75, 1063, 10.1161/HYPERTENSIONAHA.119.14294 · DOI · Paper page

Cited by

See all 191

Metadata

Authors
Guo, Y., Luo, S., Ye, Y., Yin, S., Fan, J., & Xia, M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-10-06
Volume
106
Issue
1
Pages
64-79
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3090240958
Cited by
191
References
26
FWCI
10.06
Type
journal article
Language
en
Open access
bronze
Funders
  • National Key Research and Development Program of China (2017YFC0907100, 2017YFC0907101)
  • National Natural Science Foundation of China-Guangdong Joint Fund (U1801281)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. https://app.cochat.ai/papers/10.1210/clinem/dgaa644
The paper
Guo, Y., Luo, S., Ye, Y., Yin, S., Fan, J., & Xia, M. (2021). Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa644

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.